Page 23«..1020..22232425..3040..»

Category Archives: MS Treatment

MS treatment a step closer after drug shown to repair nerve coating – The Guardian

Posted: Published on September 28th, 2020

Doctors believe they are closer to a treatment for multiple sclerosis after discovering a drug that repairs the coatings around nerves that are damaged by the disease. A clinical trial of the cancer drug bexarotene showed that it repaired the protective myelin sheaths that MS destroys Continue reading

Posted in MS Treatment | Comments Off on MS treatment a step closer after drug shown to repair nerve coating – The Guardian

Immunotherapy Slows Disability in Patients With Active Relapses During Secondary Progressive MS – Neurology Advisor

Posted: Published on September 28th, 2020

In patients with active relapses during secondary progressive multiple sclerosis (SPMS), treatment with disease-modifying therapies (DMTs) may slow the rate of disability accumulation, according to study results published in JAMA Neurology. Additionally, the study findings indicated that the rate of disability progression following disease onset was not dependent on early disease course/treatment. There is limited data available regarding the association of relapses and DMTs with the rate of disability accumulation in patients with SPMS. Continue reading

Posted in MS Treatment | Comments Off on Immunotherapy Slows Disability in Patients With Active Relapses During Secondary Progressive MS – Neurology Advisor

AbbVie Receives Orphan Drug and Fast Track Designations from the US Food and Drug Administration for Elezanumab, an Investigational Monoclonal…

Posted: Published on September 28th, 2020

NORTH CHICAGO, Ill., Sept. 28, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an investigational treatment for patients following spinal cord injury. Continue reading

Posted in MS Treatment | Comments Off on AbbVie Receives Orphan Drug and Fast Track Designations from the US Food and Drug Administration for Elezanumab, an Investigational Monoclonal…

Photos of the Week: Sept. 20-27, 2020 – The Wall Street Journal

Posted: Published on September 28th, 2020

Sept. 27, 2020 7:00 am ET Community members in the Khayelitsha township in Cape Town, South Africa, work to rebuild their homes. Amid the coronavirus, police are tearing down shacks built on public land by people who can no longer pay rent on their previous homes Continue reading

Posted in MS Treatment | Comments Off on Photos of the Week: Sept. 20-27, 2020 – The Wall Street Journal

Evidence of an Increased Burden of Humoral Autoimmunity in the CSF and plasma of COVID-19 Patients with Comorbid Neurologic Dysfunction – Newswise

Posted: Published on September 28th, 2020

Newswise Background: Coronavirus disease 19 (COVID-19) is the most globally impactful pandemic of the past century. The causative pathogen, SARS-CoV-2, infects ACE2-expressing cells and leads to pulmonary disease and a systemic immune response. Continue reading

Posted in MS Treatment | Comments Off on Evidence of an Increased Burden of Humoral Autoimmunity in the CSF and plasma of COVID-19 Patients with Comorbid Neurologic Dysfunction – Newswise

Global Multiple Sclerosis Market Outlook 2019-In-Depth Insight Of Sales Analysis, Growth Forecast And Upcoming Trends 2026 – The Daily Chronicle

Posted: Published on September 28th, 2020

A new business intelligence report released by Data Bridge Market Research with title Global Multiple Sclerosis Market are taken from trustworthy sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts. Market research report is always helpful to business or organization in every subject of trade for taking better decisions, solving the toughest business questions and minimizing the risk of failure. Continue reading

Posted in MS Treatment | Comments Off on Global Multiple Sclerosis Market Outlook 2019-In-Depth Insight Of Sales Analysis, Growth Forecast And Upcoming Trends 2026 – The Daily Chronicle

RealSelf Announces New Appointment to Board of Directors – PRNewswire

Posted: Published on September 28th, 2020

"I am thrilled to welcome Lizette to our Board of Directors," said Tom Seery, RealSelf founder and chief executive officer. "Her marketing and advertising experience will accelerate our drive to grow the RealSelf brand and innovate in a way that's relevant to our customers and to our partners Continue reading

Posted in MS Treatment | Comments Off on RealSelf Announces New Appointment to Board of Directors – PRNewswire

I used to be Ms Covid Casual. But with a sick sister, thats changed – The Guardian

Posted: Published on September 28th, 2020

Five months ago, I wrote about my sister, a junior doctor at a large hospital, and my fears for her as she worked on what is frequently described as the frontline of the Covid-19 crisis, as if she were a soldier at war, as opposed to someone who just wanted to make people feel better. Well, grab me a turban and call me Mystic Meg, because youll never guess what happened next Continue reading

Posted in MS Treatment | Comments Off on I used to be Ms Covid Casual. But with a sick sister, thats changed – The Guardian

Treating Comorbidities in Patients With ADHD – Psych Congress Network

Posted: Published on September 28th, 2020

(Part 2of 4) In this video, Psych Congress2020 cochair Vladimir Maletic, MD, MS, discusses the risks associated with comorbid conditions in patients with attention deficit/hyperactivity disorder (ADHD) and strategies for treating them. Dr. Continue reading

Posted in MS Treatment | Comments Off on Treating Comorbidities in Patients With ADHD – Psych Congress Network

Innovent Biologics Announces to Host 2020 Virtual R&D Day on November 10th – BioSpace

Posted: Published on September 28th, 2020

SAN FRANCISCO and SUZHOU, China, Sept. 28, 2020 /PRNewswire/ -- Innovent Biologics, Inc Continue reading

Posted in MS Treatment | Comments Off on Innovent Biologics Announces to Host 2020 Virtual R&D Day on November 10th – BioSpace

Page 23«..1020..22232425..3040..»